Microvision (MVIS) Financials

Microvision logo
$1.03 -0.02 (-1.90%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$1.04 +0.01 (+1.46%)
As of 11/16/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Microvision

Annual Income Statements for Microvision

This table shows Microvision's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-15 -16 -25 -27 -26 -14 -43 -53 -83 -97 -95
Consolidated Net Income / (Loss)
-15 -16 -25 -27 -26 -14 -43 -53 -83 -97 -95
Net Income / (Loss) Continuing Operations
-15 -16 -25 -27 -26 -14 -43 -53 -83 -97 -95
Total Pre-Tax Income
-15 -16 -25 -27 -26 -14 -43 -53 -82 -96 -95
Total Operating Income
-15 -16 -25 -27 -26 -14 -44 -54 -89 -86 -83
Total Gross Profit
2.01 4.39 -0.23 6.97 0.32 1.69 2.50 0.56 4.49 -2.83 -17
Total Revenue
9.19 15 9.63 18 8.89 3.09 2.50 0.66 7.26 4.70 1.21
Operating Revenue
9.19 15 9.63 18 8.89 3.09 2.50 0.66 7.26 4.70 1.21
Total Cost of Revenue
7.18 10 9.86 11 8.56 1.40 0.00 0.10 2.77 7.53 19
Operating Cost of Revenue
7.18 10 9.86 11 8.56 1.40 0.00 0.10 2.77 7.53 19
Total Operating Expenses
17 21 25 34 27 15 46 54 93 83 65
Selling, General & Admin Expense
7.88 8.74 10 9.52 8.13 5.92 22 24 37 29 20
Research & Development Expense
8.68 12 15 25 19 9.84 24 30 57 49 32
Impairment Charge
- - - - - - - 0.00 0.00 4.18 13
Other Special Charges / (Income)
-0.00 -0.03 - - 0.00 -0.45 0.00 0.00 -0.03 0.14 0.00
Total Other Income / (Expense), net
0.00 0.00 0.00 0.00 -0.01 0.00 0.67 0.80 7.18 -11 -12
Interest Expense
- - - - 0.00 0.00 -0.69 0.06 0.08 4.46 23
Other Income / (Expense), net
- - - - -0.01 - -0.02 0.86 7.26 -6.43 11
Income Tax Expense
- - - - - - 0.00 0.00 1.15 0.51 -0.08
Weighted Average Basic Shares Outstanding
46.54M 51.96M 72.79M 86.98M 111.30M 139.83M 160.66M 165.96M 182.80M 209.51M 273.14M
Diluted Earnings per Share
($0.31) ($0.32) ($0.35) ($0.31) ($0.24) ($0.10) ($0.27) ($0.32) ($0.45) ($0.46) ($0.35)
Weighted Average Diluted Shares Outstanding
46.54M 51.96M 72.79M 86.98M 111.30M 139.83M 160.66M 165.96M 182.80M 209.51M 273.14M
Weighted Average Basic & Diluted Shares Outstanding
46.54M 51.96M 72.79M 86.98M 111.30M 139.83K 160.66M 175.82M 195.27M 245.00M 306.58M

Quarterly Income Statements for Microvision

This table shows Microvision's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-26 -24 -16 -31 -29 -14 -14 -38 -25 -37 -12
Consolidated Net Income / (Loss)
-26 -24 -16 -31 -29 -14 -14 -38 -25 -37 -12
Net Income / (Loss) Continuing Operations
-26 -24 -16 -31 -29 -14 -14 -38 -25 -37 -12
Total Pre-Tax Income
-26 -24 -15 -31 -29 -14 -14 -38 -25 -37 -12
Total Operating Income
-27 -25 -16 -18 -14 -15 -13 -41 -23 -24 -21
Total Gross Profit
-0.32 0.35 -0.39 -2.47 0.04 -0.56 -0.72 -16 0.36 0.64 1.20
Total Revenue
0.96 1.90 0.19 1.65 0.59 0.16 0.24 0.22 0.94 1.47 2.40
Operating Revenue
0.96 1.90 0.19 1.65 0.59 0.16 0.24 0.22 0.94 1.47 2.40
Total Cost of Revenue
1.28 1.55 0.58 4.12 0.55 0.72 0.96 16 0.57 0.83 1.20
Operating Cost of Revenue
1.28 1.55 0.58 4.12 0.55 0.72 0.96 16 0.57 0.83 1.20
Total Operating Expenses
26 25 15 16 14 14 12 25 24 25 23
Selling, General & Admin Expense
9.08 7.75 6.60 5.92 6.68 6.44 4.03 3.19 9.51 9.21 9.36
Research & Development Expense
17 14 8.74 8.76 7.40 7.66 7.98 8.68 14 16 13
Impairment Charge
- 3.03 0.00 - 0.00 0.00 0.00 - 0.01 0.00 0.00
Other Special Charges / (Income)
- - -0.02 - 0.00 0.00 0.00 - -0.11 -0.06 -0.00
Total Other Income / (Expense), net
0.63 0.79 0.30 -13 -15 0.52 -1.32 3.23 -1.62 -13 9.14
Interest Expense
0.02 0.01 0.02 - 18 2.17 2.20 1.26 5.84 5.48 1.91
Other Income / (Expense), net
0.65 0.80 0.32 -8.15 2.89 2.69 0.87 4.49 4.22 -7.07 11
Income Tax Expense
0.23 0.08 0.11 0.08 0.07 0.09 0.17 -0.42 0.18 0.18 0.03
Basic Earnings per Share
($0.13) ($0.11) ($0.07) - ($0.12) ($0.84) ($0.72) - ($0.08) ($1.66) ($0.45)
Weighted Average Basic Shares Outstanding
196.75M 208.67M 213.00M 209.51M 235.93M 16.98M 19.70M 273.14M 308.65M 22.30M 27.39M
Diluted Earnings per Share
($0.13) ($0.11) ($0.07) - ($0.12) ($0.84) ($0.72) ($0.12) ($0.08) ($1.66) ($0.45)
Weighted Average Diluted Shares Outstanding
196.75M 208.67M 213.00M 209.51M 235.93M 16.98M 19.70M 273.14M 308.65M 22.30M 27.39M
Weighted Average Basic & Diluted Shares Outstanding
206.66M 212.75M 219.02M 245.00M 249.26M 300.96M 305.40M 306.58M 331.62M 23.79M 34.05M

Annual Cash Flow Statements for Microvision

This table details how cash moves in and out of Microvision's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-0.46 7.25 1.83 -3.20 -7.93 11 66 -62 27 6.86 -22
Net Cash From Operating Activities
-5.83 -15 -15 -23 -24 -16 -29 -38 -67 -69 -59
Net Cash From Continuing Operating Activities
-5.41 -15 -11 -24 -24 -16 -29 -38 -67 -69 -59
Net Income / (Loss) Continuing Operations
-15 -16 -25 -27 -26 -14 -43 -53 -83 -97 -95
Consolidated Net Income / (Loss)
-15 -16 -25 -27 -26 -14 -43 -53 -83 -97 -95
Depreciation Expense
0.43 1.12 1.14 1.84 1.65 0.96 1.46 2.25 7.86 6.92 5.82
Amortization Expense
0.13 0.13 0.12 - - - - 0.00 0.00 4.38 11
Non-Cash Adjustments To Reconcile Net Income
1.23 1.44 2.25 5.68 4.41 0.37 16 16 13 26 25
Changes in Operating Assets and Liabilities, net
6.93 -1.03 6.50 -2.84 -3.57 -3.77 -3.27 -2.81 -5.36 -9.15 -6.05
Net Cash From Investing Activities
-1.14 -0.89 -3.04 -1.12 -0.75 0.12 -35 -38 22 2.67 -25
Net Cash From Continuing Investing Activities
-1.14 -0.89 -3.04 -1.12 -0.75 0.12 -35 -38 22 2.67 -25
Purchase of Property, Plant & Equipment
-1.14 -0.90 -3.10 -1.12 -0.75 -0.40 -2.49 -4.36 -1.94 -0.37 -0.68
Acquisitions
- - - - - - 0.00 -4.13 -11 -6.30 0.00
Purchase of Investments
- - - - 0.00 0.00 -33 -90 -42 -26 -52
Sale and/or Maturity of Investments
- - - - - 0.00 0.00 61 77 35 30
Other Investing Activities, net
- - - - - 0.00 - - 0.00 0.00 -2.24
Net Cash From Financing Activities
6.51 23 20 20 17 27 131 14 72 73 61
Net Cash From Continuing Financing Activities
6.51 23 20 20 17 27 131 14 72 73 61
Repayment of Debt
- - - - -0.02 0.00 -0.49 -0.39 0.00 0.00 -17
Issuance of Debt
0.00 0.02 0.00 0.01 0.00 1.57 - 0.00 0.00 38 0.00
Issuance of Common Equity
6.51 23 20 20 17 24 123 14 72 35 77
Other Financing Activities, net
- - - 0.14 0.00 0.97 8.76 0.70 0.15 0.06 -0.01
Effect of Exchange Rate Changes
- - - - - - 0.00 0.00 0.27 -0.17 0.32

Quarterly Cash Flow Statements for Microvision

This table details how cash moves in and out of Microvision's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-3.05 -18 -10 38 -2.72 22 -1.26 -40 14 -19 1.46
Net Cash From Operating Activities
-21 -19 -14 -15 -14 -13 -16 -15 -16 -19 -14
Net Cash From Continuing Operating Activities
-21 -19 -14 -15 -14 -13 -16 -15 -16 -19 -14
Net Income / (Loss) Continuing Operations
-26 -24 -16 -31 -29 -14 -14 -38 -25 -37 -12
Consolidated Net Income / (Loss)
-26 -24 -16 -31 -29 -14 -14 -38 -25 -37 -12
Depreciation Expense
1.80 1.77 1.68 1.67 1.41 1.54 1.40 1.48 2.37 2.98 2.93
Amortization Expense
0.00 - - - 5.56 2.16 2.19 1.25 2.74 5.48 1.89
Non-Cash Adjustments To Reconcile Net Income
3.48 6.55 2.26 14 11 -0.90 -2.43 17 -0.22 8.41 -1.85
Changes in Operating Assets and Liabilities, net
0.28 -3.03 -2.51 -3.90 -3.47 -1.31 -3.43 2.15 3.96 0.93 -4.37
Net Cash From Investing Activities
-3.28 -4.13 3.58 6.50 3.09 -0.32 -9.39 -18 9.21 -0.31 -1.37
Net Cash From Continuing Investing Activities
-3.28 -4.13 3.58 6.50 3.09 -0.32 -9.39 -18 9.21 -0.31 -1.37
Purchase of Property, Plant & Equipment
-0.11 -0.17 0.01 -0.10 -0.10 -0.21 -0.13 -0.24 -0.14 -0.31 -1.37
Net Cash From Financing Activities
21 5.15 -0.02 47 8.21 35 24 -6.89 21 0.35 17
Net Cash From Continuing Financing Activities
21 5.15 -0.02 47 8.21 35 24 -6.89 21 0.35 17
Issuance of Common Equity
21 5.15 -0.02 8.66 8.21 35 30 4.11 0.31 0.46 17
Other Financing Activities, net
0.06 - - - -0.00 -0.00 -0.00 0.01 -0.00 -0.01 -0.00
Effect of Exchange Rate Changes
-0.03 0.06 0.11 -0.30 0.08 0.24 0.15 -0.15 -0.07 0.19 -0.11

Annual Balance Sheets for Microvision

This table presents Microvision's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
14 20 30 23 12 21 130 115 130 121 103
Total Current Assets
11 17 23 18 7.84 18 119 91 87 82 81
Cash & Equivalents
7.89 15 17 14 5.84 17 83 21 45 54 32
Restricted Cash
- - - - - - - 0.00 3.26 0.26 0.50
Short-Term Investments
- - - - - - 33 62 29 20 42
Accounts Receivable
1.69 0.37 0.70 1.46 1.08 - - 0.00 0.95 0.93 0.05
Inventories, net
0.86 1.23 4.54 1.11 0.19 0.00 1.78 1.86 3.87 2.29 0.75
Other Current Assets
0.64 0.61 1.02 1.31 0.73 0.70 2.28 6.44 4.89 4.29 4.99
Plant, Property, & Equipment, net
1.67 1.54 3.25 2.99 1.85 1.88 3.03 6.83 9.03 7.06 4.28
Total Noncurrent Assets
1.30 1.22 3.30 2.39 2.15 1.56 7.77 17 34 32 18
Goodwill
- - - - - - - - - - 0.00
Intangible Assets
0.85 0.72 0.60 0.49 0.22 0.16 0.12 0.08 17 11 0.03
Other Noncurrent Operating Assets
0.02 0.07 2.26 1.47 1.49 1.40 7.65 17 17 21 18
Total Liabilities & Shareholders' Equity
14 20 30 23 12 21 130 115 130 121 103
Total Liabilities
14 13 20 19 16 12 17 25 34 72 48
Total Current Liabilities
7.70 7.24 19 18 14 10 12 11 21 46 30
Short-Term Debt
- - 0.00 0.02 0.00 0.43 0.39 0.00 0.00 24 19
Accounts Payable
2.18 2.20 3.06 2.41 1.87 0.63 3.58 2.06 2.27 1.13 1.63
Accrued Expenses
3.40 3.70 5.86 5.60 2.05 0.50 1.17 2.06 15 2.54 5.43
Current Deferred Revenue
2.12 1.17 0.01 0.00 9.78 7.77 5.27 4.60 - 0.31 0.00
Other Current Liabilities
- 0.18 10 10 0.76 0.71 2.05 2.71 3.29 18 3.88
Total Noncurrent Liabilities
6.49 5.39 0.61 0.73 1.36 1.97 5.01 14 13 26 17
Capital Lease Obligations
- - 0.00 0.03 0.01 0.04 0.03 - 13 0.00 14
Other Noncurrent Operating Liabilities
- - - 0.00 1.35 0.77 4.98 14 0.61 18 3.36
Commitments & Contingencies
- - - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-0.15 7.47 10 4.12 -3.98 9.01 113 90 96 49 56
Total Preferred & Common Equity
-0.15 7.47 10 4.12 -3.98 9.01 113 90 96 49 56
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-0.15 7.47 10 4.12 -3.98 9.01 113 90 96 49 56
Common Stock
483 507 529 550 569 595 742 772 861 911 1,012
Retained Earnings
-483 -500 -519 -546 -573 -586 -629 -683 -765 -862 -957
Accumulated Other Comprehensive Income / (Loss)
- - - - - - -0.02 -0.13 0.21 0.00 0.67

Quarterly Balance Sheets for Microvision

This table presents Microvision's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
149 136 124 103 88 117 141 151 110 89 91
Total Current Assets
103 91 82 67 53 79 103 115 54 34 38
Cash & Equivalents
62 49 44 27 17 52 74 73 46 27 29
Restricted Cash
3.26 3.26 0.07 0.07 0.27 0.07 0.08 0.33 0.49 0.48 0.26
Short-Term Investments
32 29 29 30 27 17 17 27 0.00 0.00 0.00
Accounts Receivable
0.82 0.74 1.12 1.97 0.23 0.25 0.10 0.04 0.73 0.92 1.40
Inventories, net
2.93 3.62 3.74 4.20 4.49 2.53 6.13 8.13 4.03 3.66 4.40
Other Current Assets
2.33 5.77 4.30 3.65 4.86 7.10 5.47 6.97 2.86 2.02 2.89
Plant, Property, & Equipment, net
9.95 9.46 8.55 8.13 7.67 6.82 6.74 6.57 17 16 16
Total Noncurrent Assets
35 35 33 29 28 31 31 29 39 39 37
Goodwill
- - - - - - - - 3.68 3.68 3.68
Intangible Assets
18 18 17 13 13 11 11 10 14 14 13
Other Noncurrent Operating Assets
17 17 17 16 15 20 20 19 21 21 20
Total Liabilities & Shareholders' Equity
149 136 124 103 88 117 141 151 110 89 91
Total Liabilities
36 38 30 25 22 64 64 60 71 68 68
Total Current Liabilities
23 24 18 13 11 42 43 40 52 50 47
Short-Term Debt
8.48 8.55 5.14 0.00 0.00 30 32 29 32 25 23
Accounts Payable
1.89 2.29 2.16 1.45 1.49 1.27 1.56 1.34 4.54 5.88 6.36
Accrued Expenses
6.60 7.20 9.97 8.89 5.89 2.19 2.27 3.75 7.54 7.51 5.66
Current Deferred Revenue
5.73 4.96 0.21 0.17 0.18 - 0.34 0.15 0.41 0.25 0.13
Other Current Liabilities
0.00 1.06 0.27 2.14 3.05 8.29 6.39 5.70 7.13 12 12
Total Noncurrent Liabilities
13 14 13 12 12 22 21 20 19 18 21
Capital Lease Obligations
- - - - - 15 0.03 0.03 16 16 0.01
Other Noncurrent Operating Liabilities
13 14 13 12 12 6.22 21 20 2.62 1.80 21
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
113 98 94 79 66 53 77 91 40 21 23
Total Preferred & Common Equity
113 98 94 79 66 53 77 91 40 21 23
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
113 98 94 79 66 53 77 91 40 21 23
Common Stock
835 844 885 894 897 944 982 1,010 1,022 1,039 1,054
Retained Earnings
-722 -746 -792 -816 -831 -891 -905 -920 -983 -1,019 -1,032
Accumulated Other Comprehensive Income / (Loss)
-0.01 0.05 0.16 0.10 0.34 0.12 0.52 0.65 0.56 0.74 0.61

Annual Metrics And Ratios for Microvision

This table displays calculated financial ratios and metrics derived from Microvision's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
47,232,000.00 53,944,000.00 78,594,000.00 93,073,343.00 119,417,078.00 146,405,910.00 164,103,810.00 - - - 305,397,269.00
DEI Adjusted Shares Outstanding
47,232,000.00 53,944,000.00 78,594,000.00 93,073,343.00 119,417,078.00 146,405,910.00 164,103,810.00 - - - 305,397,269.00
DEI Earnings Per Adjusted Shares Outstanding
-0.31 -0.31 -0.32 -0.29 -0.22 -0.09 -0.26 - - - -0.31
Growth Metrics
- - - - - - - - - - -
Revenue Growth
163.64% 60.66% -34.73% 82.76% -49.53% -65.23% -19.09% -73.44% 993.22% -35.31% -74.28%
EBITDA Growth
20.44% -8.70% -59.25% -4.78% 2.16% 49.05% -235.35% -19.69% -45.23% -9.35% 31.94%
EBIT Growth
19.77% -13.11% -54.82% -6.83% 2.71% 48.59% -222.38% -20.82% -53.91% -12.66% 21.83%
NOPAT Growth
-10.50% -13.11% -54.82% -6.83% 2.75% 48.57% -222.21% -22.84% -64.92% 3.78% 3.15%
Net Income Growth
19.75% -13.27% -54.72% -6.92% 2.81% 48.52% -216.85% -22.90% -56.04% -16.99% 2.00%
EPS Growth
29.55% -3.23% -9.38% 11.43% 22.58% 58.33% -170.00% -18.52% -40.63% 0.00% 23.91%
Operating Cash Flow Growth
55.01% -154.35% -4.44% -45.82% -6.52% 33.14% -82.92% -29.30% -76.46% -2.16% 14.33%
Free Cash Flow Firm Growth
75.55% -230.01% -57.94% 15.04% -14.26% 26.07% -156.51% -35.15% -84.57% 40.98% -43.85%
Invested Capital Growth
-343.31% 5.06% 12.89% -43.08% -2.09% 39.19% 64.75% 420.36% 347.63% -27.69% -107.99%
Revenue Q/Q Growth
14.44% 7.73% -5.89% -2.59% 45.34% -57.67% 6.93% -45.62% 236.38% -42.36% -54.16%
EBITDA Q/Q Growth
-6.87% -4.51% -13.25% -17.75% 25.40% -2.55% -26.52% -0.23% 2.79% -3.70% -32.87%
EBIT Q/Q Growth
-6.97% -6.76% -12.22% -16.33% 24.61% -2.13% -26.08% -0.98% 1.65% -8.69% -16.63%
NOPAT Q/Q Growth
-6.97% -6.76% -12.22% -16.33% 24.64% -2.13% -26.02% -2.62% -7.10% 1.63% -38.30%
Net Income Q/Q Growth
-7.01% -6.96% -12.09% -16.35% 24.65% -2.14% -26.52% -1.63% -8.18% -13.35% -7.47%
EPS Q/Q Growth
-14.81% -3.23% 0.00% -6.90% -20.00% 50.00% 0.00% 0.00% -4.65% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-11.97% -2.04% -31.07% 16.69% -5.25% 6.43% -20.26% -0.65% -13.88% 2.17% -0.60%
Free Cash Flow Firm Q/Q Growth
-24.89% -3.85% -85.15% 42.85% -29.56% -2.12% -14.39% -13.94% -6.69% 11.41% -28.44%
Invested Capital Q/Q Growth
-2.75% -6.81% 47.03% -544.19% 14.72% 22.90% -5.73% 196.83% 23.42% 1.69% -102.74%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.85% 29.72% -2.37% 39.58% 3.62% 54.76% 99.92% 84.94% 61.81% -60.35% -1,435.43%
EBITDA Margin
-152.30% -103.05% -251.43% -144.16% -279.47% -409.45% -1,697.12% -7,648.04% -1,016.01% -1,717.40% -4,544.04%
Operating Margin
-158.36% -111.50% -264.48% -154.60% -297.91% -440.61% -1,754.76% -8,115.96% -1,224.34% -1,821.10% -6,856.62%
EBIT Margin
-158.36% -111.50% -264.48% -154.60% -298.03% -440.61% -1,755.68% -7,986.30% -1,124.34% -1,958.07% -5,950.33%
Profit (Net Income) Margin
-158.27% -111.59% -264.54% -154.77% -298.03% -441.23% -1,728.00% -7,995.63% -1,141.23% -2,063.78% -7,862.67%
Tax Burden Percent
99.95% 100.09% 100.02% 100.11% 100.00% 100.14% 100.00% 100.00% 101.40% 100.53% 99.91%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 98.42% 100.12% 100.10% 104.85% 132.26%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,559.77% -323.11% -220.74% -1,851.20%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -1,544.22% -295.05% -138.71% -1,775.73%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1,507.33% 233.81% 86.67% 1,669.10%
Return on Equity (ROE)
-432.86% -449.99% -290.27% -383.72% -37,832.86% -541.89% -70.96% -52.44% -89.30% -134.07% -182.10%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -667.66% -450.06% -188.60% 0.00%
Operating Return on Assets (OROA)
-111.98% -96.39% -102.18% -103.11% -151.90% -82.91% -58.05% -43.25% -66.73% -73.33% -64.10%
Return on Assets (ROA)
-111.92% -96.47% -102.20% -103.22% -151.90% -83.03% -57.13% -43.30% -67.73% -77.29% -84.70%
Return on Common Equity (ROCE)
-432.86% -449.99% -290.27% -383.72% -37,832.86% -541.89% -70.96% -52.44% -89.30% -134.07% -182.10%
Return on Equity Simple (ROE_SIMPLE)
0.00% -220.39% -252.69% -661.89% 665.90% -151.34% -38.31% -59.16% -86.47% -198.72% 0.00%
Net Operating Profit after Tax (NOPAT)
-10 -12 -18 -19 -19 -9.53 -31 -38 -62 -60 -58
NOPAT Margin
-110.85% -78.05% -185.14% -108.22% -208.53% -308.43% -1,228.33% -5,681.17% -857.04% -1,274.77% -4,799.64%
Net Nonoperating Expense Percent (NNEP)
-50.94% -41.53% -46.91% -52.47% -77.93% -38.17% -19.19% -15.55% -28.06% -82.03% -75.47%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -42.04% -57.33% -61.26% -77.53%
Cost of Revenue to Revenue
78.15% 70.28% 102.37% 60.42% 96.38% 45.24% 0.08% 15.06% 38.19% 160.35% 1,535.43%
SG&A Expenses to Revenue
85.75% 59.23% 105.42% 54.09% 91.53% 191.49% 890.24% 3,620.63% 505.43% 624.91% 1,682.53%
R&D to Revenue
94.47% 82.20% 156.70% 140.09% 210.00% 318.45% 964.44% 4,580.27% 781.20% 1,043.76% 2,625.83%
Operating Expenses to Revenue
180.21% 141.22% 262.11% 194.18% 301.53% 495.37% 1,854.68% 8,200.90% 1,286.16% 1,760.75% 5,421.19%
Earnings before Interest and Taxes (EBIT)
-15 -16 -25 -27 -26 -14 -44 -53 -82 -92 -72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-14 -15 -24 -25 -25 -13 -42 -51 -74 -81 -55
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 9.09 12.70 13.65 0.00 87.43 7.29 4.35 5.28 5.88 4.55
Price to Tangible Book Value (P/TBV)
0.00 10.06 13.51 15.48 0.00 89.05 7.30 4.35 6.43 7.59 4.56
Price to Revenue (P/Rev)
14.70 4.60 13.30 3.19 9.68 254.91 328.86 587.62 69.62 61.10 209.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 43.73 14.01 11.46 0.00
Enterprise Value to Revenue (EV/Rev)
13.84 3.58 11.57 2.41 9.02 249.98 282.88 463.06 60.76 55.56 162.92
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.01 0.03 0.01 0.00 0.18 0.00 0.00 0.13 1.00 0.35
Long-Term Debt to Equity
0.00 0.01 0.03 0.01 0.00 0.13 0.00 0.00 0.13 0.51 0.00
Financial Leverage
-2.55 -3.26 -1.86 -2.20 -145.79 -4.27 -1.07 -0.98 -0.79 -0.62 -0.94
Leverage Ratio
3.87 4.66 2.84 3.72 249.06 6.53 1.24 1.21 1.32 1.73 2.15
Compound Leverage Factor
3.87 4.66 2.84 3.72 249.06 6.53 1.22 1.21 1.32 1.82 2.84
Debt to Total Capital
0.00% 0.70% 2.94% 1.29% -0.23% 15.29% 0.37% 0.00% 11.72% 50.10% 25.73%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.50% 0.00% 4.05% 0.35% 0.00% 0.00% 24.81% 25.69%
Long-Term Debt to Total Capital
0.00% 0.70% 2.94% 0.79% -0.23% 11.24% 0.02% 0.00% 11.72% 25.28% 0.04%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 99.30% 97.06% 98.71% 100.23% 84.71% 99.63% 100.00% 88.28% 49.90% 74.27%
Debt to EBITDA
0.00 0.00 -0.01 0.00 0.00 -0.13 -0.01 0.00 -0.17 -0.61 -0.35
Net Debt to EBITDA
0.00 0.99 0.69 0.54 0.23 1.20 2.71 0.00 0.87 0.32 1.02
Long-Term Debt to EBITDA
0.00 0.00 -0.01 0.00 0.00 -0.09 0.00 0.00 -0.17 -0.31 0.00
Debt to NOPAT
0.00 0.00 -0.02 0.00 0.00 -0.17 -0.01 0.00 -0.20 -0.82 -0.33
Net Debt to NOPAT
0.00 1.31 0.93 0.72 0.31 1.60 3.74 0.00 1.03 0.43 0.97
Long-Term Debt to NOPAT
0.00 0.00 -0.02 0.00 0.00 -0.13 0.00 0.00 -0.20 -0.41 0.00
Altman Z-Score
-44.96 -32.94 -22.83 -34.57 -71.77 -1.24 21.36 0.28 -0.71 -9.69 -11.50
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.44 2.39 1.22 0.97 0.54 1.75 9.58 7.97 4.23 1.79 2.69
Quick Ratio
1.24 2.14 0.93 0.84 0.48 1.68 9.26 7.24 3.64 1.65 2.48
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3.62 -12 -19 -16 -18 -14 -35 -47 -87 -51 -51
Operating Cash Flow to CapEx
-511.14% -1,663.41% -509.01% -2,018.96% -3,227.25% 0.00% -1,179.46% -872.20% -3,467.18% -18,326.20% -8,648.01%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -757.26 -1,083.22 -11.48 -2.18
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -613.21 -838.63 -15.38 -2.53
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -683.52 -862.81 -15.46 -2.56
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.71 0.86 0.39 0.67 0.51 0.19 0.03 0.01 0.06 0.04 0.01
Accounts Receivable Turnover
7.80 14.35 18.09 16.32 6.99 0.00 0.00 0.00 0.00 5.01 2.48
Inventory Turnover
14.68 9.90 3.42 3.77 13.17 0.00 0.00 0.05 0.97 2.44 12.21
Fixed Asset Turnover
7.17 9.21 4.02 5.64 3.67 1.66 1.02 0.13 0.92 0.58 0.21
Accounts Payable Turnover
3.77 4.74 3.75 3.89 4.00 1.12 0.00 0.04 1.28 4.43 13.44
Days Sales Outstanding (DSO)
46.80 25.43 20.17 22.37 52.21 0.00 0.00 0.00 0.00 72.87 147.00
Days Inventory Outstanding (DIO)
24.86 36.86 106.85 96.93 27.72 0.00 0.00 6,644.83 377.57 149.49 29.90
Days Payable Outstanding (DPO)
96.82 77.02 97.30 93.91 91.25 326.49 384,527.50 10,302.13 285.21 82.48 27.16
Cash Conversion Cycle (CCC)
-25.16 -14.73 29.72 25.39 -11.32 -326.49 -384,527.50 -3,657.30 92.37 139.88 149.74
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-8.48 -8.05 -7.01 -10 -10 -6.23 -2.20 7.03 31 23 -0.54
Invested Capital Turnover
-1.77 -1.79 -1.28 -2.07 -0.88 -0.38 -0.59 0.27 0.38 0.17 0.39
Increase / (Decrease) in Invested Capital
-6.56 0.43 1.04 -3.02 -0.21 4.01 4.03 9.23 24 -8.72 -7.35
Enterprise Value (EV)
127 53 111 42 80 772 707 307 441 261 197
Market Capitalization
135 68 128 56 86 788 822 390 505 287 253
Book Value per Share
$0.00 $0.14 $0.13 $0.04 ($0.03) $0.06 $0.69 $0.54 $0.50 $0.22 $0.18
Tangible Book Value per Share
($0.02) $0.13 $0.12 $0.04 ($0.04) $0.06 $0.69 $0.54 $0.41 $0.17 $0.18
Total Capital
-0.15 7.53 10 4.17 -3.97 11 113 90 109 98 75
Total Debt
0.00 0.05 0.31 0.05 0.01 1.63 0.42 0.00 13 49 19
Total Long-Term Debt
0.00 0.05 0.31 0.03 0.01 1.20 0.03 0.00 13 25 0.03
Net Debt
-7.89 -15 -17 -14 -5.83 -15 -115 -83 -64 -26 -56
Capital Expenditures (CapEx)
1.14 0.89 3.04 1.12 0.75 -0.12 2.49 4.36 1.94 0.37 0.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-4.52 -5.04 -13 -14 -12 -8.90 -8.01 -3.13 -11 -14 -5.16
Debt-free Net Working Capital (DFNWC)
3.37 10 4.14 -0.52 -6.62 7.96 107 80 66 61 70
Net Working Capital (NWC)
3.37 10 4.14 -0.54 -6.62 7.53 107 80 66 37 51
Net Nonoperating Expense (NNE)
4.36 4.95 7.65 8.20 7.95 4.10 12 15 21 37 37
Net Nonoperating Obligations (NNO)
-8.32 -16 -17 -14 -6.26 -15 -115 -83 -64 -26 -56
Total Depreciation and Amortization (D&A)
0.56 1.25 1.26 1.84 1.65 0.96 1.46 2.25 7.86 11 17
Debt-free, Cash-free Net Working Capital to Revenue
-49.16% -34.11% -133.10% -81.13% -140.18% -287.99% -320.28% -470.93% -148.64% -302.30% -426.82%
Debt-free Net Working Capital to Revenue
36.69% 68.45% 43.00% -2.94% -74.49% 257.70% 4,294.40% 11,985.24% 912.67% 1,294.02% 5,809.19%
Net Working Capital to Revenue
36.69% 68.45% 43.00% -3.06% -74.49% 243.75% 4,278.72% 11,985.24% 912.67% 777.66% 4,218.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.31) ($0.32) ($0.33) ($0.31) ($0.24) $0.00 ($0.27) ($0.32) ($0.45) $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
47.44M 68.12M 78.61M 102.11M 128.08M 0.00 164.63M 165.96M 182.80M 209.51M 273.14M
Adjusted Diluted Earnings per Share
($0.31) ($0.32) ($0.33) ($0.31) ($0.24) $0.00 ($0.27) ($0.32) ($0.45) $0.00 ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding
47.44M 68.12M 78.61M 102.11M 128.08M 0.00 164.63M 165.96M 182.80M 209.51M 273.14M
Adjusted Basic & Diluted Earnings per Share
($0.31) ($0.32) ($0.33) ($0.31) ($0.24) ($0.10) ($0.27) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
46.54M 51.96M 72.79M 86.98M 111.30M 139.83M 160.66M 175.82M 195.27M 245.00M 306.58M
Normalized Net Operating Profit after Tax (NOPAT)
-10 -12 -18 -19 -19 -9.85 -31 -38 -62 -57 -49
Normalized NOPAT Margin
-110.86% -78.20% -185.14% -108.22% -208.53% -318.62% -1,228.33% -5,681.17% -857.37% -1,210.32% -4,020.65%
Pre Tax Income Margin
-158.36% -111.50% -264.48% -154.60% -298.03% -440.61% -1,728.00% -7,995.63% -1,125.44% -2,052.98% -7,869.62%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -855.31 -1,020.20 -20.63 -3.10
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -608.44 -777.66 -13.43 -2.50
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -925.61 -1,044.39 -20.71 -3.13
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -678.74 -801.84 -13.52 -2.53
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Microvision

This table displays calculated financial ratios and metrics derived from Microvision's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 245,004,785.00 249,261,553.00 300,964,884.00 305,397,269.00 306,579,855.00 331,615,285.00 23,788,425.00
DEI Adjusted Shares Outstanding
- - - - 245,004,785.00 249,261,553.00 300,964,884.00 305,397,269.00 306,579,855.00 22,107,686.00 23,788,425.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.12 -0.06 -0.05 -0.12 -0.08 -1.67 -0.51
Growth Metrics
- - - - - - - - - - -
Revenue Growth
22.25% 477.51% -81.85% -67.65% -38.39% -91.84% 26.84% -86.48% 58.74% 850.32% 895.85%
EBITDA Growth
-48.75% -18.03% 34.98% -41.67% 82.76% 62.57% 39.75% -65.87% -238.71% -176.46% 33.76%
EBIT Growth
-38.38% -17.29% 33.75% -38.76% 57.22% 49.79% 23.00% -38.43% -72.89% -161.42% 13.17%
NOPAT Growth
-26.04% -3.06% 34.27% 7.12% 47.44% 40.50% 19.01% -124.18% -67.34% -65.20% -67.73%
Net Income Growth
-38.29% -16.11% 33.88% -57.85% -9.37% 40.54% 8.38% -21.19% 12.11% -159.63% 13.99%
EPS Growth
-18.18% 8.33% 41.67% 0.00% 7.69% 45.45% 28.57% 20.00% 33.33% -159.63% 37.50%
Operating Cash Flow Growth
-53.98% -11.97% 30.89% 9.18% 32.09% 31.69% -17.01% -2.32% -16.63% -50.40% 17.30%
Free Cash Flow Firm Growth
3.68% 60.40% 80.25% 89.01% 52.73% 59.41% 18.73% -284.31% -105.66% -418.27% -75.97%
Invested Capital Growth
65.98% -7.96% -12.24% -27.69% 14.95% -18.37% -11.20% -107.99% 39.45% 85.52% -18.49%
Revenue Q/Q Growth
-81.26% 98.74% -90.00% 768.42% -64.30% -73.68% 55.48% -7.47% 319.28% 57.54% 62.93%
EBITDA Q/Q Growth
-37.28% 9.07% 37.79% -81.63% 79.71% -97.47% -0.04% -313.88% 58.57% -61.17% 76.03%
EBIT Q/Q Growth
-35.39% 8.56% 35.38% -72.74% 58.19% -7.33% 0.99% -211.59% 47.79% -62.28% 67.11%
NOPAT Q/Q Growth
-34.30% 7.78% 36.23% -17.61% 23.99% -4.39% 13.20% -225.53% 43.27% -3.05% 11.87%
Net Income Q/Q Growth
-33.32% 9.06% 35.16% -100.78% 7.63% 50.56% 0.08% -165.57% 33.01% -46.05% 66.90%
EPS Q/Q Growth
-30.00% 15.38% 36.36% 0.00% 20.00% 50.00% 16.67% -140.00% 33.33% -46.05% 72.89%
Operating Cash Flow Q/Q Growth
-25.22% 10.24% 24.38% -6.85% 6.36% 9.71% -29.53% 6.57% -6.74% -16.43% 28.78%
Free Cash Flow Firm Q/Q Growth
9.39% 47.01% 48.68% 46.46% -216.59% 54.50% -2.75% -238.13% -30.09% -14.66% 65.11%
Invested Capital Q/Q Growth
2.94% -14.91% 1.95% 1.69% 335.63% -39.57% 10.91% -102.74% 7,702.76% -19.61% -51.27%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
-33.58% 18.21% -206.84% -149.45% 6.62% -361.94% -297.10% -7,220.63% 38.82% 43.58% 49.96%
EBITDA Margin
-2,539.64% -1,161.89% -7,227.89% -1,511.70% -710.02% -5,327.74% -3,427.80% -15,332.29% -1,514.97% -1,549.90% -228.00%
Operating Margin
-2,793.93% -1,296.37% -8,266.32% -1,119.52% -2,383.70% -9,455.48% -5,278.42% -18,569.96% -2,512.73% -1,643.65% -889.04%
EBIT Margin
-2,727.93% -1,255.05% -8,110.00% -1,613.15% -1,892.87% -7,720.00% -4,916.18% -16,554.71% -2,061.60% -2,123.69% -428.67%
Profit (Net Income) Margin
-2,752.41% -1,259.47% -8,166.84% -1,888.18% -4,886.08% -9,180.00% -5,899.17% -16,930.94% -2,705.24% -2,508.01% -509.50%
Tax Burden Percent
100.90% 100.35% 100.70% 100.26% 100.25% 100.66% 101.22% 98.89% 100.72% 100.49% 100.27%
Interest Burden Percent
100.00% 100.00% 100.00% 116.74% 257.48% 118.13% 118.54% 103.42% 130.28% 117.52% 118.54%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-703.23% -356.75% -1,968.88% -135.70% -260.50% -857.81% -460.77% -5,013.65% -76.98% -129.15% -173.56%
ROIC Less NNEP Spread (ROIC-NNEP)
-692.27% -347.55% -1,961.10% -95.35% -219.10% -850.97% -451.47% -4,995.77% 4.46% -43.25% -180.56%
Return on Net Nonoperating Assets (RNNOA)
533.56% 264.29% 1,388.87% 59.58% 136.44% 633.18% 329.62% 4,695.78% -1.05% 20.60% 123.15%
Return on Equity (ROE)
-169.66% -92.46% -580.02% -76.12% -124.05% -224.63% -131.15% -317.87% -78.02% -108.55% -50.41%
Cash Return on Invested Capital (CROIC)
-369.25% -282.44% -241.13% -188.60% -197.82% -200.52% -186.54% 0.00% -214.87% -338.53% -408.23%
Operating Return on Assets (OROA)
-163.89% -89.66% -589.38% -60.41% -68.02% -163.49% -108.36% -178.33% -28.23% -53.22% -17.85%
Return on Assets (ROA)
-165.36% -89.98% -593.51% -70.71% -175.59% -194.41% -130.03% -182.38% -37.05% -62.85% -21.21%
Return on Common Equity (ROCE)
-169.66% -92.46% -580.02% -76.12% -124.05% -224.63% -131.15% -317.87% -78.02% -108.55% -50.41%
Return on Equity Simple (ROE_SIMPLE)
-96.08% -118.73% -129.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-19 -17 -11 -13 -9.83 -10 -8.90 -29 -16 -17 -15
NOPAT Margin
-1,955.75% -907.46% -5,786.42% -783.66% -1,668.59% -6,618.84% -3,694.90% -12,998.97% -1,758.91% -1,150.56% -622.33%
Net Nonoperating Expense Percent (NNEP)
-10.96% -9.20% -7.78% -40.35% -41.40% -6.85% -9.29% -17.88% -81.44% -85.90% 7.00%
Return On Investment Capital (ROIC_SIMPLE)
- - - -13.23% -9.95% -9.38% -7.44% -38.76% -18.70% -27.81% -32.93%
Cost of Revenue to Revenue
133.58% 81.79% 306.84% 249.45% 93.38% 461.94% 397.10% 7,320.63% 61.18% 56.42% 50.04%
SG&A Expenses to Revenue
949.58% 407.68% 3,473.16% 358.97% 1,133.45% 4,152.90% 1,670.95% 1,428.25% 1,017.22% 625.32% 389.96%
R&D to Revenue
1,810.77% 747.58% 4,597.89% 531.15% 1,256.88% 4,940.65% 3,310.37% 3,892.83% 1,544.92% 1,065.99% 549.17%
Operating Expenses to Revenue
2,760.36% 1,314.58% 8,059.47% 970.06% 2,390.32% 9,093.55% 4,981.33% 11,349.33% 2,551.55% 1,687.24% 939.00%
Earnings before Interest and Taxes (EBIT)
-26 -24 -15 -27 -11 -12 -12 -37 -19 -31 -10
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-24 -22 -14 -25 -4.18 -8.26 -8.26 -34 -14 -23 -5.47
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.83 2.78 3.68 5.88 5.71 3.69 4.11 4.55 4.97 5.26 1.57
Price to Tangible Book Value (P/TBV)
4.66 3.34 4.55 7.59 7.15 4.27 4.64 4.56 8.85 33.28 6.25
Price to Revenue (P/Rev)
48.34 24.33 29.77 61.10 70.18 109.97 141.63 209.35 126.50 37.76 7.09
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
11.29 7.39 8.89 11.46 9.45 12.55 15.21 0.00 4.80 3.64 1.80
Enterprise Value to Revenue (EV/Rev)
39.19 18.03 24.43 55.56 64.74 87.07 114.75 162.92 127.67 42.15 5.79
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.05 0.00 0.00 1.00 0.86 0.42 0.32 0.35 1.22 1.96 0.99
Long-Term Debt to Equity
0.00 0.00 0.00 0.51 0.29 0.00 0.00 0.00 0.41 0.76 0.00
Financial Leverage
-0.77 -0.76 -0.71 -0.62 -0.62 -0.74 -0.73 -0.94 -0.23 -0.48 -0.68
Leverage Ratio
1.37 1.32 1.37 1.73 1.64 1.57 1.53 2.15 2.45 2.35 2.13
Compound Leverage Factor
1.37 1.32 1.37 2.03 4.22 1.85 1.81 2.22 3.19 2.76 2.52
Debt to Total Capital
5.19% 0.00% 0.00% 50.10% 46.13% 29.52% 24.22% 25.73% 55.05% 66.16% 49.85%
Short-Term Debt to Total Capital
5.19% 0.00% 0.00% 24.81% 30.48% 29.50% 24.19% 25.69% 36.54% 40.30% 49.82%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 25.28% 15.65% 0.03% 0.03% 0.04% 18.51% 25.86% 0.03%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
94.81% 100.00% 100.00% 49.90% 53.87% 70.48% 75.78% 74.27% 44.95% 33.84% 50.15%
Debt to EBITDA
-0.06 0.00 0.00 -0.61 -0.75 -0.69 -0.70 -0.35 -0.75 -0.51 -0.29
Net Debt to EBITDA
0.83 0.00 0.00 0.32 0.39 1.27 1.71 1.02 -0.03 -0.16 0.09
Long-Term Debt to EBITDA
0.00 0.00 0.00 -0.31 -0.26 0.00 0.00 0.00 -0.25 -0.20 0.00
Debt to NOPAT
-0.08 0.00 0.00 -0.82 -0.89 -0.73 -0.69 -0.33 -0.75 -0.57 -0.29
Net Debt to NOPAT
1.03 0.00 0.00 0.43 0.46 1.34 1.69 0.97 -0.03 -0.18 0.08
Long-Term Debt to NOPAT
0.00 0.00 0.00 -0.41 -0.30 0.00 0.00 0.00 -0.25 -0.22 0.00
Altman Z-Score
-1.84 -5.77 -6.60 -7.91 -7.71 -6.08 -4.45 -10.38 -11.35 -16.50 -16.03
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.64 5.26 5.00 1.79 1.89 2.41 2.88 2.69 1.05 0.68 0.80
Quick Ratio
4.18 4.64 4.09 1.65 1.66 2.14 2.50 2.48 0.91 0.56 0.64
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-29 -15 -7.87 -4.22 -14 -6.23 -6.40 -22 -28 -32 -11
Operating Cash Flow to CapEx
-18,209.65% -11,225.30% 0.00% -14,617.48% -14,240.40% -6,119.71% -12,881.25% -6,313.52% -11,498.60% -6,277.05% -997.51%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -0.78 -2.87 -2.91 -17.16 -4.82 -5.89 -5.90
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 -0.80 -5.87 -7.50 -12.22 -2.82 -3.49 -7.15
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -0.81 -5.96 -7.56 -12.41 -2.84 -3.55 -7.87
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.06 0.07 0.07 0.04 0.04 0.02 0.02 0.01 0.01 0.03 0.04
Accounts Receivable Turnover
9.14 6.45 16.76 5.01 6.31 2.49 19.38 2.48 3.16 5.64 6.97
Inventory Turnover
1.02 1.22 1.07 2.44 2.17 1.15 1.00 12.21 5.66 3.82 3.02
Fixed Asset Turnover
0.79 1.00 0.95 0.58 0.56 0.35 0.37 0.21 0.13 0.26 0.45
Accounts Payable Turnover
1.21 2.61 2.28 4.43 3.97 3.96 4.49 13.44 6.40 5.02 4.92
Days Sales Outstanding (DSO)
39.95 56.57 21.77 72.87 57.88 146.48 18.84 147.00 115.56 64.75 52.38
Days Inventory Outstanding (DIO)
356.88 298.83 342.59 149.49 168.26 316.08 363.24 29.90 64.49 95.60 120.84
Days Payable Outstanding (DPO)
301.48 139.79 159.88 82.48 91.99 92.15 81.36 27.16 57.05 72.67 74.19
Cash Conversion Cycle (CCC)
95.35 215.62 204.49 139.88 134.15 370.41 300.72 149.74 123.00 87.69 99.04
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
26 22 22 23 30 18 20 -0.54 41 33 16
Invested Capital Turnover
0.36 0.39 0.34 0.17 0.16 0.13 0.12 0.39 0.04 0.11 0.28
Increase / (Decrease) in Invested Capital
10 -1.90 -3.12 -8.72 3.86 -4.03 -2.51 -7.35 12 15 -3.68
Enterprise Value (EV)
291 162 199 261 280 225 302 197 198 121 29
Market Capitalization
359 219 243 287 304 284 373 253 197 108 36
Book Value per Share
$0.48 $0.38 $0.31 $0.22 $0.22 $0.31 $0.30 $0.18 $0.13 $0.06 $0.96
Tangible Book Value per Share
$0.40 $0.32 $0.25 $0.17 $0.17 $0.27 $0.27 $0.18 $0.07 $0.01 $0.24
Total Capital
99 79 66 98 99 109 120 75 88 61 45
Total Debt
5.14 0.00 0.00 49 46 32 29 19 48 40 23
Total Long-Term Debt
0.00 0.00 0.00 25 15 0.03 0.03 0.03 16 16 0.01
Net Debt
-68 -57 -43 -26 -24 -59 -71 -56 1.82 13 -6.55
Capital Expenditures (CapEx)
0.11 0.17 -0.01 0.10 0.10 0.21 0.13 0.24 0.14 0.31 1.37
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-3.45 -2.83 -1.04 -14 -1.86 1.14 4.20 -5.16 -12 -19 -16
Debt-free Net Working Capital (DFNWC)
70 54 42 61 67 93 104 70 35 8.42 13
Net Working Capital (NWC)
65 54 42 37 37 60 75 51 2.46 -16 -9.29
Net Nonoperating Expense (NNE)
7.62 6.69 4.52 18 19 3.97 5.31 8.77 8.85 20 -2.71
Net Nonoperating Obligations (NNO)
-68 -57 -43 -26 -24 -59 -71 -56 1.82 13 -6.55
Total Depreciation and Amortization (D&A)
1.80 1.77 1.68 1.67 6.97 3.71 3.59 2.73 5.11 8.45 4.82
Debt-free, Cash-free Net Working Capital to Revenue
-46.47% -31.45% -12.72% -302.30% -42.99% 44.20% 159.54% -426.82% -772.46% -670.93% -315.03%
Debt-free Net Working Capital to Revenue
937.51% 598.88% 520.88% 1,294.02% 1,553.55% 3,584.56% 3,948.39% 5,809.19% 2,226.58% 293.21% 264.46%
Net Working Capital to Revenue
868.41% 598.88% 520.88% 777.66% 858.07% 2,335.68% 2,849.22% 4,218.79% 158.30% -561.91% -184.66%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.13) ($0.11) ($0.07) $0.00 ($0.12) ($0.06) ($0.05) $0.00 ($0.08) ($1.66) ($0.45)
Adjusted Weighted Average Basic Shares Outstanding
196.75M 208.67M 213.00M 209.51M 235.93M 254.66M 295.46M 273.14M 308.65M 22.30M 27.39M
Adjusted Diluted Earnings per Share
($0.13) ($0.11) ($0.07) $0.00 ($0.12) ($0.06) ($0.05) ($0.12) ($0.08) ($1.66) ($0.45)
Adjusted Weighted Average Diluted Shares Outstanding
196.75M 208.67M 213.00M 209.51M 235.93M 254.66M 295.46M 273.14M 308.65M 22.30M 27.39M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
206.66M 212.75M 219.02M 245.00M 249.26M 300.96M 305.40M 306.58M 331.62M 23.79M 34.05M
Normalized Net Operating Profit after Tax (NOPAT)
-19 -15 -11 -13 -9.83 -10 -8.90 -29 -17 -17 -15
Normalized NOPAT Margin
-1,955.75% -795.94% -5,794.53% -783.66% -1,668.59% -6,618.84% -3,694.90% -12,998.97% -1,766.32% -1,153.41% -622.42%
Pre Tax Income Margin
-2,727.93% -1,255.05% -8,110.00% -1,883.27% -4,873.68% -9,120.00% -5,827.80% -17,120.18% -2,685.78% -2,495.72% -508.13%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 -0.64 -5.51 -5.39 -29.28 -3.30 -5.71 -5.39
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 -0.56 -4.73 -4.05 -22.99 -2.82 -3.09 -7.83
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -0.64 -5.61 -5.45 -29.47 -3.33 -5.76 -6.11
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -0.57 -4.82 -4.11 -23.18 -2.84 -3.15 -8.55
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Microvision’s Q2 2026 results show improving revenue, but the company remains deeply unprofitable and cash-flow negative. Revenue increased to $1.5 million from $935,000 in Q1 2026 and $155,000 in Q2 2025. Gross profit was $642,000, representing a gross margin of approximately 44%. However, operating expenses totaled $24.9 million, led by $15.7 million of research and development spending and $9.2 million of selling, general and administrative costs.

The company reported a net loss of $36.9 million, or $1.66 per share, in Q2 2026. This was substantially worse than the $25.3 million loss in Q1 2026 and the $14.2 million loss in Q2 2025. Interest expense also increased to $5.5 million, while other income and expense produced a net expense of $7.1 million.

Cash consumption remains a major concern. Operating activities used $19.1 million during Q2 2026, compared with $16.4 million in Q1 2026 and $12.7 million in Q2 2025. After investing and financing activity, cash and equivalents declined by $18.9 million during the quarter, leaving $27.2 million of cash at June 30, 2026. At the latest quarterly operating burn rate, the reported cash balance alone represents roughly one to two quarters of operating funding, although future financing, asset sales, or changes in spending could alter that estimate.

The balance sheet also weakened during the quarter. Total assets declined from $110.2 million at March 31, 2026, to $88.6 million at June 30, while total equity fell from $39.5 million to $20.6 million. Current liabilities of $50.4 million exceeded current assets of $34.3 million, producing a current ratio below 1.0. Short-term debt declined to $24.6 million from $32.1 million, but capital lease obligations remained significant at $15.8 million.

Several years of quarterly data show a persistent pattern of operating losses and negative operating cash flow. Revenue has improved from the very low levels recorded in 2025, but it remains far below Q2 2024 revenue of $1.9 million and Q4 2023 revenue of $5.1 million. Investors should also note that several historical statements are marked as restated or calculated, and the sharp changes in reported share counts suggest that per-share comparisons may be affected by corporate actions.

  • Revenue is showing sequential and year-over-year improvement: Q2 2026 revenue of $1.5 million rose approximately 57% from Q1 2026 and more than 800% from Q2 2025.
  • Gross profitability returned: Q2 2026 gross profit was $642,000, compared with gross losses in Q2 2025, Q3 2025, and Q4 2025.
  • Short-term debt declined: Short-term debt fell by approximately $7.6 million from Q1 2026 to Q2 2026, partially reducing near-term repayment pressure.
  • No impairment charge was recorded in Q2 2026: The company reported no impairment expense during the quarter, unlike the impairment charge recorded in Q2 2025.
  • Research and development spending remains elevated: R&D spending increased to $15.7 million in Q2 2026, supporting product development but requiring substantial external funding while revenue remains limited.
  • Working-capital movements provided modest support: Changes in operating assets and liabilities contributed $933,000 of cash during Q2 2026, although this benefit was not large enough to offset the operating loss.
  • Net losses are widening: The Q2 2026 net loss of $36.9 million was substantially higher than the losses reported in Q1 2026 and Q2 2025.
  • Operating cash flow remains persistently negative: Microvision has reported significant operating cash outflows in each of the supplied quarterly periods, including $19.1 million in Q2 2026.
  • Liquidity has deteriorated: Cash declined from $46.1 million to $27.2 million during Q2 2026, while the company held $50.4 million of current liabilities against $34.3 million of current assets.
  • Financing and dilution risk remain high: The company has repeatedly relied on equity issuance and other financing activity, while its accumulated deficit reached approximately $1.02 billion and its retained earnings remained deeply negative.
11/17/26 02:00 AM ETAI Generated. May Contain Errors.

Microvision Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Microvision's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Microvision's net income appears to be on a downward trend, with a most recent value of -$94.98 million in 2025, falling from -$14.54 million in 2015. The previous period was -$96.92 million in 2024. See Microvision's forecast for analyst expectations on what's next for the company.

Microvision's total operating income in 2025 was -$82.83 million, based on the following breakdown:
  • Total Gross Profit: -$17.34 million
  • Total Operating Expenses: $65.49 million

Over the last 10 years, Microvision's total revenue changed from $9.19 million in 2015 to $1.21 million in 2025, a change of -86.9%.

In the past 13 quarters, Microvision's cash and equivalents has ranged from $16.52 million in Q3 2024 to $74.09 million in Q2 2025, and is currently $28.89 million as of their latest financial filing in Q3 2026.

Microvision had total debt of $19.24 million at the end of 2025, a 60.7% decrease from 2024, and none in 2015.

Over the last 10 years, Microvision's book value per share changed from 0.00 in 2015 to 0.18 in 2025.



Financial statements for NASDAQ:MVIS last updated on 10/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners